The NLEP, India is a Centrally Sponsored Scheme under the umbrella of NHM.
The major concern of the Programme is to detect cases of leprosy at an early stage and provide complete treatment, free of cost, in order to prevent occurrence of Grade II Disability (G2D) in affected persons.
Under NLEP, it is aimed to reduce G2D per million population to less than 1 per million population and to have zero G2D among new child cases aligned with the target given by Global Leprosy Strategy 2016-20.
